First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients.

Journal: Practical radiation oncology
Published Date:

Abstract

PURPOSE: To assess the clinical acceptability of a commercial deep-learning-based auto-segmentation (DLAS) prostate model that was retrained using institutional data for delineation of the clinical target volume (CTV) and organs-at-risk (OARs) for postprostatectomy patients, accounting for clinical and imaging protocol variations.

Authors

  • Dean Hobbis
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Nathan Y Yu
    Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ (Y.H., J.H., S.H.P., N.Y.Y., W.L.); Cornell University, Ithaca, NY (Y.H.); Department of Electric Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA (Y.H.); and Department of Radiation Oncology, Mayo Clinic, Rochester, MN (A.B., E.L.M., D.K.E., D.M.R., S.S., C.L.H., B.E.B., M.W.).
  • Karl W Mund
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Jingwei Duan
    Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Jean-Claude M Rwigema
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • William W Wong
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Steven E Schild
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Sameer R Keole
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Xue Feng
    Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia.
  • Quan Chen
    Management School, Zhongshan Institute, University of Electronic Science and Technology of China, Guangdong, 528402, China.
  • Carlos E Vargas
    Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Yi Rong
    Department of Radiation Oncology, University of California Davis Medical Center, Sacramento, CA, United States.